Skip to main content

Research Repository

Advanced Search

Deoxycholic acid as a molecular scaffold for tyrosyl-DNA phosphodiesterase 1 inhibition: A synthesis, structure–activity relationship and molecular modeling study

Salomatina, Oksana V.; Popadyuk, Irina I.; Zakharenko, Alexandra L.; Zakharova, Olga D.; Chepanova, Arina A.; Dyrkheeva, Nadezhda.S.; Komarova, Nina I.; Reynisson, Jóhannes; Anarbaev, Rashid O.; Salakhutdinov, Nariman F.; Lavrik, Olga I.; Volcho, Konstantin P.

Authors

Oksana V. Salomatina

Irina I. Popadyuk

Alexandra L. Zakharenko

Olga D. Zakharova

Arina A. Chepanova

Nadezhda.S. Dyrkheeva

Nina I. Komarova

Rashid O. Anarbaev

Nariman F. Salakhutdinov

Olga I. Lavrik

Konstantin P. Volcho



Abstract

Para-Bromoanilides of deoxycholic acid with various functional groups on the steroid scaffold were designed as promising tyrosyl-DNA phosphodiesterase 1 (Tdp1) inhibitors. Tdp1 is a DNA repair enzyme, involved in removing DNA damage caused by topoisomerase I poisons; an important class of anticancer drugs. Thus, reducing the activity of Tdp1 can increase the efficacy of anticancer drugs in current use. Inhibitory activity in the low micromolar and submicromolar concentrations was observed with 3,12-dimethoxy para-bromoanilide 17 being the most active with an IC50 value of 0.27 μM. The activity of N-methyl para-bromoanilides was 3–4.8 times lower than of the corresponding para-bromoanilides. Increased potency of the ligands was seen with higher molecular weight and log P values. The ligands were evaluated for their cytotoxic potential in a panel of tumor cell lines; all were nontoxic to the A549 pulmonary adenocarcinoma cell line. However, derivatives containing a hydroxyl group at the 12th position were more toxic than their 12-hydroxyl group counterparts (acetoxy-, oxo- and methoxy- group) against HCT-116 human colon and HepG2 hepatocellular carcinomas. In addition, an N-methyl substitution led to an increase in toxicity for the HCT-116 and HepG2 cell lines. The excellent activity as well as low cytotoxicity, derivative 17 can be considered as a lead compound for further development.

Citation

Salomatina, O. V., Popadyuk, I. I., Zakharenko, A. L., Zakharova, O. D., Chepanova, A. A., Dyrkheeva, N., …Volcho, K. P. (2021). Deoxycholic acid as a molecular scaffold for tyrosyl-DNA phosphodiesterase 1 inhibition: A synthesis, structure–activity relationship and molecular modeling study. Steroids, 165, Article 108771. https://doi.org/10.1016/j.steroids.2020.108771

Journal Article Type Article
Acceptance Date Nov 14, 2020
Online Publication Date Nov 19, 2020
Publication Date 2021-01
Deposit Date Jun 2, 2023
Journal Steroids
Print ISSN 0039-128X
Electronic ISSN 1878-5867
Publisher Elsevier
Peer Reviewed Peer Reviewed
Volume 165
Article Number 108771
DOI https://doi.org/10.1016/j.steroids.2020.108771
Keywords Organic Chemistry; Clinical Biochemistry; Pharmacology; Endocrinology; Molecular Biology; Biochemistry
Additional Information This article is maintained by: Elsevier; Article Title: Deoxycholic acid as a molecular scaffold for tyrosyl-DNA phosphodiesterase 1 inhibition: A synthesis, structure–activity relationship and molecular modeling study; Journal Title: Steroids; CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.steroids.2020.108771; Content Type: article; Copyright: © 2020 Published by Elsevier Inc.